Clinical Trial Update: Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating droxidopa to increase mean arterial pressure in patients with decompensated cirrhosis and acute kidney injury; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Decompensated Cirrhosis of the Liver
• Kidney Injury

Drugs mentioned

• Northera (droxidopa)

Snippet

Sponsor: Giuseppe Cullaro, MD | Conditions: Acute Kidney Injury, Cirrhosis | Phase 2 | Status: RECRUITING